The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global ST2 Biomarker Market Research Report 2025
Synopsis
Cardiac biomarkers are the substances that are released into the bloodstream when the heart is stressed or damaged. Suppression of tumorigenicity 2 (ST2) is one such biomarker used to help in measurement of heart failure risk to assess the treatment options. The ST2 biomarker is a member of the interleukin-1 receptor family biomarker. It is a strong predictor and most promising biomarker for both chronic and acute heart failure.
The global ST2 Biomarker market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for ST2 Biomarker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for ST2 Biomarker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for ST2 Biomarker in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of ST2 Biomarker include Thermo Fisher Scientific, BD, Roche, Abbott, Siemens, Bio-Rad and BioMerieux, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for ST2 Biomarker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding ST2 Biomarker.
Report Scope
The ST2 Biomarker market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global ST2 Biomarker market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the ST2 Biomarker companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
BD
Roche
Abbott
Siemens
Bio-Rad
BioMerieux
Segment by Type
ELISA Based ST2 Biomarker
Immunochromatography Based ST2 Biomarker
Segment by Application
Hospitals
Diagnostic Centres
Ambulatory Surgical Centres
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of ST2 Biomarker companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Cardiac biomarkers are the substances that are released into the bloodstream when the heart is stressed or damaged. Suppression of tumorigenicity 2 (ST2) is one such biomarker used to help in measurement of heart failure risk to assess the treatment options. The ST2 biomarker is a member of the interleukin-1 receptor family biomarker. It is a strong predictor and most promising biomarker for both chronic and acute heart failure.
The global ST2 Biomarker market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for ST2 Biomarker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for ST2 Biomarker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for ST2 Biomarker in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of ST2 Biomarker include Thermo Fisher Scientific, BD, Roche, Abbott, Siemens, Bio-Rad and BioMerieux, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for ST2 Biomarker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding ST2 Biomarker.
Report Scope
The ST2 Biomarker market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global ST2 Biomarker market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the ST2 Biomarker companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
BD
Roche
Abbott
Siemens
Bio-Rad
BioMerieux
Segment by Type
ELISA Based ST2 Biomarker
Immunochromatography Based ST2 Biomarker
Segment by Application
Hospitals
Diagnostic Centres
Ambulatory Surgical Centres
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of ST2 Biomarker companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global ST2 Biomarker Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 ELISA Based ST2 Biomarker
1.2.3 Immunochromatography Based ST2 Biomarker
1.3 Market by Application
1.3.1 Global ST2 Biomarker Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Diagnostic Centres
1.3.4 Ambulatory Surgical Centres
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global ST2 Biomarker Market Perspective (2019-2030)
2.2 ST2 Biomarker Growth Trends by Region
2.2.1 Global ST2 Biomarker Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 ST2 Biomarker Historic Market Size by Region (2019-2024)
2.2.3 ST2 Biomarker Forecasted Market Size by Region (2025-2030)
2.3 ST2 Biomarker Market Dynamics
2.3.1 ST2 Biomarker Industry Trends
2.3.2 ST2 Biomarker Market Drivers
2.3.3 ST2 Biomarker Market Challenges
2.3.4 ST2 Biomarker Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top ST2 Biomarker Players by Revenue
3.1.1 Global Top ST2 Biomarker Players by Revenue (2019-2024)
3.1.2 Global ST2 Biomarker Revenue Market Share by Players (2019-2024)
3.2 Global ST2 Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by ST2 Biomarker Revenue
3.4 Global ST2 Biomarker Market Concentration Ratio
3.4.1 Global ST2 Biomarker Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by ST2 Biomarker Revenue in 2023
3.5 ST2 Biomarker Key Players Head office and Area Served
3.6 Key Players ST2 Biomarker Product Solution and Service
3.7 Date of Enter into ST2 Biomarker Market
3.8 Mergers & Acquisitions, Expansion Plans
4 ST2 Biomarker Breakdown Data by Type
4.1 Global ST2 Biomarker Historic Market Size by Type (2019-2024)
4.2 Global ST2 Biomarker Forecasted Market Size by Type (2025-2030)
5 ST2 Biomarker Breakdown Data by Application
5.1 Global ST2 Biomarker Historic Market Size by Application (2019-2024)
5.2 Global ST2 Biomarker Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America ST2 Biomarker Market Size (2019-2030)
6.2 North America ST2 Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America ST2 Biomarker Market Size by Country (2019-2024)
6.4 North America ST2 Biomarker Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe ST2 Biomarker Market Size (2019-2030)
7.2 Europe ST2 Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe ST2 Biomarker Market Size by Country (2019-2024)
7.4 Europe ST2 Biomarker Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific ST2 Biomarker Market Size (2019-2030)
8.2 Asia-Pacific ST2 Biomarker Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific ST2 Biomarker Market Size by Region (2019-2024)
8.4 Asia-Pacific ST2 Biomarker Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America ST2 Biomarker Market Size (2019-2030)
9.2 Latin America ST2 Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America ST2 Biomarker Market Size by Country (2019-2024)
9.4 Latin America ST2 Biomarker Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa ST2 Biomarker Market Size (2019-2030)
10.2 Middle East & Africa ST2 Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa ST2 Biomarker Market Size by Country (2019-2024)
10.4 Middle East & Africa ST2 Biomarker Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific ST2 Biomarker Introduction
11.1.4 Thermo Fisher Scientific Revenue in ST2 Biomarker Business (2019-2024)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 BD
11.2.1 BD Company Detail
11.2.2 BD Business Overview
11.2.3 BD ST2 Biomarker Introduction
11.2.4 BD Revenue in ST2 Biomarker Business (2019-2024)
11.2.5 BD Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche ST2 Biomarker Introduction
11.3.4 Roche Revenue in ST2 Biomarker Business (2019-2024)
11.3.5 Roche Recent Development
11.4 Abbott
11.4.1 Abbott Company Detail
11.4.2 Abbott Business Overview
11.4.3 Abbott ST2 Biomarker Introduction
11.4.4 Abbott Revenue in ST2 Biomarker Business (2019-2024)
11.4.5 Abbott Recent Development
11.5 Siemens
11.5.1 Siemens Company Detail
11.5.2 Siemens Business Overview
11.5.3 Siemens ST2 Biomarker Introduction
11.5.4 Siemens Revenue in ST2 Biomarker Business (2019-2024)
11.5.5 Siemens Recent Development
11.6 Bio-Rad
11.6.1 Bio-Rad Company Detail
11.6.2 Bio-Rad Business Overview
11.6.3 Bio-Rad ST2 Biomarker Introduction
11.6.4 Bio-Rad Revenue in ST2 Biomarker Business (2019-2024)
11.6.5 Bio-Rad Recent Development
11.7 BioMerieux
11.7.1 BioMerieux Company Detail
11.7.2 BioMerieux Business Overview
11.7.3 BioMerieux ST2 Biomarker Introduction
11.7.4 BioMerieux Revenue in ST2 Biomarker Business (2019-2024)
11.7.5 BioMerieux Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global ST2 Biomarker Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of ELISA Based ST2 Biomarker
Table 3. Key Players of Immunochromatography Based ST2 Biomarker
Table 4. Global ST2 Biomarker Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global ST2 Biomarker Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global ST2 Biomarker Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global ST2 Biomarker Market Share by Region (2019-2024)
Table 8. Global ST2 Biomarker Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global ST2 Biomarker Market Share by Region (2025-2030)
Table 10. ST2 Biomarker Market Trends
Table 11. ST2 Biomarker Market Drivers
Table 12. ST2 Biomarker Market Challenges
Table 13. ST2 Biomarker Market Restraints
Table 14. Global ST2 Biomarker Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global ST2 Biomarker Market Share by Players (2019-2024)
Table 16. Global Top ST2 Biomarker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ST2 Biomarker as of 2023)
Table 17. Ranking of Global Top ST2 Biomarker Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by ST2 Biomarker Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players ST2 Biomarker Product Solution and Service
Table 21. Date of Enter into ST2 Biomarker Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global ST2 Biomarker Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global ST2 Biomarker Revenue Market Share by Type (2019-2024)
Table 25. Global ST2 Biomarker Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global ST2 Biomarker Revenue Market Share by Type (2025-2030)
Table 27. Global ST2 Biomarker Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global ST2 Biomarker Revenue Market Share by Application (2019-2024)
Table 29. Global ST2 Biomarker Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global ST2 Biomarker Revenue Market Share by Application (2025-2030)
Table 31. North America ST2 Biomarker Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America ST2 Biomarker Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America ST2 Biomarker Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe ST2 Biomarker Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe ST2 Biomarker Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe ST2 Biomarker Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific ST2 Biomarker Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific ST2 Biomarker Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific ST2 Biomarker Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America ST2 Biomarker Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America ST2 Biomarker Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America ST2 Biomarker Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa ST2 Biomarker Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa ST2 Biomarker Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa ST2 Biomarker Market Size by Country (2025-2030) & (US$ Million)
Table 46. Thermo Fisher Scientific Company Detail
Table 47. Thermo Fisher Scientific Business Overview
Table 48. Thermo Fisher Scientific ST2 Biomarker Product
Table 49. Thermo Fisher Scientific Revenue in ST2 Biomarker Business (2019-2024) & (US$ Million)
Table 50. Thermo Fisher Scientific Recent Development
Table 51. BD Company Detail
Table 52. BD Business Overview
Table 53. BD ST2 Biomarker Product
Table 54. BD Revenue in ST2 Biomarker Business (2019-2024) & (US$ Million)
Table 55. BD Recent Development
Table 56. Roche Company Detail
Table 57. Roche Business Overview
Table 58. Roche ST2 Biomarker Product
Table 59. Roche Revenue in ST2 Biomarker Business (2019-2024) & (US$ Million)
Table 60. Roche Recent Development
Table 61. Abbott Company Detail
Table 62. Abbott Business Overview
Table 63. Abbott ST2 Biomarker Product
Table 64. Abbott Revenue in ST2 Biomarker Business (2019-2024) & (US$ Million)
Table 65. Abbott Recent Development
Table 66. Siemens Company Detail
Table 67. Siemens Business Overview
Table 68. Siemens ST2 Biomarker Product
Table 69. Siemens Revenue in ST2 Biomarker Business (2019-2024) & (US$ Million)
Table 70. Siemens Recent Development
Table 71. Bio-Rad Company Detail
Table 72. Bio-Rad Business Overview
Table 73. Bio-Rad ST2 Biomarker Product
Table 74. Bio-Rad Revenue in ST2 Biomarker Business (2019-2024) & (US$ Million)
Table 75. Bio-Rad Recent Development
Table 76. BioMerieux Company Detail
Table 77. BioMerieux Business Overview
Table 78. BioMerieux ST2 Biomarker Product
Table 79. BioMerieux Revenue in ST2 Biomarker Business (2019-2024) & (US$ Million)
Table 80. BioMerieux Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of Figures
Figure 1. Global ST2 Biomarker Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global ST2 Biomarker Market Share by Type: 2023 VS 2030
Figure 3. ELISA Based ST2 Biomarker Features
Figure 4. Immunochromatography Based ST2 Biomarker Features
Figure 5. Global ST2 Biomarker Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global ST2 Biomarker Market Share by Application: 2023 VS 2030
Figure 7. Hospitals Case Studies
Figure 8. Diagnostic Centres Case Studies
Figure 9. Ambulatory Surgical Centres Case Studies
Figure 10. Others Case Studies
Figure 11. ST2 Biomarker Report Years Considered
Figure 12. Global ST2 Biomarker Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global ST2 Biomarker Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global ST2 Biomarker Market Share by Region: 2023 VS 2030
Figure 15. Global ST2 Biomarker Market Share by Players in 2023
Figure 16. Global Top ST2 Biomarker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ST2 Biomarker as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by ST2 Biomarker Revenue in 2023
Figure 18. North America ST2 Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America ST2 Biomarker Market Share by Country (2019-2030)
Figure 20. United States ST2 Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada ST2 Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe ST2 Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe ST2 Biomarker Market Share by Country (2019-2030)
Figure 24. Germany ST2 Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France ST2 Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. ST2 Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy ST2 Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia ST2 Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries ST2 Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific ST2 Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific ST2 Biomarker Market Share by Region (2019-2030)
Figure 32. China ST2 Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan ST2 Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea ST2 Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia ST2 Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India ST2 Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia ST2 Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America ST2 Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America ST2 Biomarker Market Share by Country (2019-2030)
Figure 40. Mexico ST2 Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil ST2 Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa ST2 Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa ST2 Biomarker Market Share by Country (2019-2030)
Figure 44. Turkey ST2 Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia ST2 Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Thermo Fisher Scientific Revenue Growth Rate in ST2 Biomarker Business (2019-2024)
Figure 47. BD Revenue Growth Rate in ST2 Biomarker Business (2019-2024)
Figure 48. Roche Revenue Growth Rate in ST2 Biomarker Business (2019-2024)
Figure 49. Abbott Revenue Growth Rate in ST2 Biomarker Business (2019-2024)
Figure 50. Siemens Revenue Growth Rate in ST2 Biomarker Business (2019-2024)
Figure 51. Bio-Rad Revenue Growth Rate in ST2 Biomarker Business (2019-2024)
Figure 52. BioMerieux Revenue Growth Rate in ST2 Biomarker Business (2019-2024)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
